New imaging study aims to stop blindness from misdiagnosed artery inflammation
NCT ID NCT07206238
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at two conditions that can cause sudden vision loss: giant cell arteritis (GCA), a blood vessel inflammation that needs urgent treatment, and NAION, a similar condition that does not benefit from that treatment. Researchers will use special PET/MRI scans and eye imaging in 122 adults to find signs of inflammation around the eye's blood vessels. The goal is to better tell these conditions apart, so GCA patients get the right treatment quickly and NAION patients avoid unnecessary side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rigshospitalet - Glostrup
RECRUITINGGlostrup Municipality, 2600, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can frequent CRP checks prevent relapses in giant cell arteritis?
- Ultrasound clue vanishes days after steroids start in artery disease
- New Total-Body PET scanner could revolutionize vasculitis diagnosis
- New drug combo aims to tame blood vessel inflammation
- Could 8 weeks of steroids be enough? new trial aims to cut treatment time for GCA
- New ultrasound method could predict relapses in rare artery disease